幽门螺杆菌的诊断进展
Research Progress in the Diagnosis of Helicobacter pylori
摘要: 幽门螺杆菌感染是引发慢性胃炎、消化性溃疡甚至胃癌的重要诱因,精准诊断是开展临床治疗与疾病防控的核心环节。本文采用文献综述法,系统梳理2016至2026年国内外相关期刊论文、Meta分析及临床研究文献,从侵入性诊断、非侵入性诊断、内镜相关诊断三大维度归纳幽门螺杆菌各类检测技术的应用现状与诊断效能。文章总结了尿素呼气试验、粪便抗原检测、病理染色、内镜征象评估等方法的优势与适用人群,详细阐释侧向流免疫分析、CRISPR/Cas基因靶向检测等新型技术的检测原理、研发进展与临床转化瓶颈,分析目前临床存在的特殊人群诊断标准不统一、基层检测技术普及滞后、新型快速诊断技术临床转化缓慢等现实问题。在此基础上提出6项具体研究方向,摒弃宏观发展理念,聚焦可落地的科学问题,以期为临床合理选择诊断方式、开展幽门螺杆菌感染规范化诊疗提供理论参考。
Abstract: Helicobacter pylori infection is an important inducement of chronic gastritis, peptic ulcer and even gastric cancer, and accurate diagnosis is the key link for clinical treatment and disease prevention and control. Adopting the literature review method, this paper systematically sorts out relevant domestic and foreign journal papers, meta-analyses and clinical research literature from 2016 to 2026. It summarizes the application status and diagnostic efficacy of various detection technologies for Helicobacter pylori from three dimensions of invasive diagnosis, non-invasive diagnosis and endoscopic-related diagnosis. This paper concludes the advantages and applicable crowds of methods such as urea breath test, stool antigen detection, pathological staining and endoscopic sign evaluation, expounds the detection principle, research progress and clinical transformation bottlenecks of new technologies such as lateral flow immunoassay and CRISPR/Cas gene targeted detection, and analyzes practical problems including inconsistent diagnostic standards for special populations, lagging popularization of grassroots detection technology, and slow clinical transformation of new rapid diagnostic technology. On this basis, 6 specific research directions are proposed to abandon the macroscopic development concepts and focus on implementable scientific issues, so as to provide theoretical reference for clinical rational selection of diagnosis methods and standardized diagnosis and treatment of Helicobacter pylori infection.
文章引用:李述, 杨志平. 幽门螺杆菌的诊断进展[J]. 临床医学进展, 2026, 16(6): 1294-1300. https://doi.org/10.12677/acm.2026.1662339

参考文献

[1] 史彬, 刘楠洋, 毕红岩, 等. 中医药治疗幽门螺杆菌感染研究进展[J]. 中国中西医结合杂志, 2017, 37(4): 507-511.
[2] 刘雪霏, 付勇, 何妙侠. 幽门螺杆菌相关性慢性胃炎与胃淋巴瘤的相关性研究进展[J]. 中华病理学杂志, 2020, 49(9): 983-987.
[3] 王俊敏, 王姗, 郜茜. 京都胃炎评分联合白光内镜黏膜表现评估幽门螺杆菌感染状态的应用价值[J]. 中华消化内镜杂志, 2026, 43(2): 142-146.
[4] 许鑫博, 何丛, 祝荫. 幽门螺杆菌与胃癌防治的新进展[J]. 上海医学, 2022, 45(11): 791-794.
[5] 文睿, 程天恒, 王妮涵, 等. 幽门螺杆菌治疗药物研究进展[J]. 中国药学杂志, 2024, 59(18): 1695-1704.
[6] 李伟鹏, 周鸿科, 柏小芬, 等. 幽门螺杆菌感染与胃肠外疾病关系的研究进展[J]. 广东医学, 2016, 37(11): 1731-1733.
[7] 程丹丹, 何丛, 吕农华. 幽门螺杆菌感染与代谢综合征的研究进展[J]. 中华消化杂志, 2016, 36(1): 68-70.
[8] Dong, Y., Zhu, J. and Pan, N. (2025) Recent Advances in Rapid Detection of Helicobacter pylori by Lateral Flow Assay. Archives of Microbiology, 207, Article No. 35. [Google Scholar] [CrossRef] [PubMed]
[9] 刘彦霞, 桑田, 杨延辉, 等. 幽门螺杆菌在胃炎癌变过程中作用机制的研究进展[J]. 中华消化杂志, 2026, 46(01): 62-65.
[10] 吕农华, 谢川. 第五次全国幽门螺杆菌感染处理共识报告的背景与亮点[J]. 上海医学, 2017, 40(12): 717-719.
[11] 郑天乐, 张语诺, 钟心怡, 等. 慢性萎缩性胃炎患者舌象特征研究进展分析[J]. 中国医药学报, 2024, 39(3): 1410-1413.
[12] Siregar, G.A., Parwati, I., Achmad, T.H. and Syukriani, Y.F. (2018) Risk Factors of Gastric Premalignant Lesion in Gastritis Patients. Sains Malaysiana, 47, 1811-1818. [Google Scholar] [CrossRef
[13] Kim, B. (2024) When to Diagnose and Treat Helicobacter pylori? In: Kim, B.W., Ed., Helicobacter Infection in Clinical Practice, Springer, 3-7. [Google Scholar] [CrossRef
[14] 马丹, 孟凡冬. 幽门螺杆菌感染与胃癌的早期诊治[J]. 中华内科杂志, 2020, 59(5): 392-394.
[15] 万维松, 王乐, 胡余昌, 等. 免疫组化染色与14C尿素呼气试验在幽门螺杆菌相关胃炎诊断中的比较[J]. 临床与实验病理学杂志, 2019, 35(1): 47-50.
[16] 陈海云, 胡悦, 肖培宇, 等. 幽门螺杆菌检测方法的效能比较及组织病理学特征分析[J]. 重庆医学, 2026, 55(2): 374-380.
[17] 赖妙玲, 廖德贵, 曾嘉敏, 等. 三种方法检测胃黏膜活检标本幽门螺杆菌感染的病理诊断价值[J]. 临床与实验病理学杂志, 2021, 37(11): 1377-1380.
[18] 赵媛媛, 许建明, 张磊, 等. 幽门螺杆菌感染常用诊断方法的对比研究[J]. 中华消化内镜杂志, 2016, 33(6): 379-383.
[19] Cutler, A.F., Havstad, S., Ma, C.K., Blaser, M.J., Perez-Perez, G.I. and Schubert, T.T. (1995) Accuracy of Invasive and Noninvasive Tests to Diagnose Helicobacter pylori Infection. Gastroenterology, 109, 136-141. [Google Scholar] [CrossRef] [PubMed]
[20] 周显祝, 许诗涵, 杜奕奇, 等. 幽门螺杆菌研究四十周年——中国学者的贡献[J]. 中华消化内镜杂志, 2025, 42(12): 925-931.
[21] Miftahussurur, M. and Yamaoka, Y. (2016) Diagnostic Methods of Helicobacter pylori Infection for Epidemiological Studies: Critical Importance of Indirect Test Validation. BioMed Research International, 2016, Article ID: 819423. [Google Scholar] [CrossRef] [PubMed]
[22] Tai, D., Jalal, M., Tun, G., Chetcuti-Zammit, S. and McAlindon, M. (2019) PTU-121 the Value of Endoscopic Biopsies in Routine Upper Gastrointestinal Endoscopy. Gut, 68, A55. [Google Scholar] [CrossRef
[23] 廖桂彬, 龚嘉倩, 赵利娜, 等. 尿素呼气试验和粪便抗原检测对消化性溃疡出血患者幽门螺杆菌感染诊断价值的Meta分析[J]. 中国全科医学, 2022, 25(3): 354-362.
[24] 李志平, 孙海洋, 姜愚烽, 等. 粪便抗原检测和13C呼吸试验对儿童幽门螺杆菌感染诊断价值的系统评价和Meta分析[J]. 现代预防医学, 2017, 44(23): 4412-4416.
[25] 李萍, 杨聪英, 张天啸, 等. 尿素呼气试验检测值对成人幽门螺杆菌初始根除效果的预测作用[J]. 西安交通大学学报(医学版), 2026, 47(1): 140-145.
[26] Spinelli, I., Porcari, S., Esposito, C., Fusco, W., Ponziani, F.R., Caruso, C., et al. (2025) Meta‐Analysis: Inverse Association between Helicobacter pylori Infection and Eosinophilic Oesophagitis. Alimentary Pharmacology & Therapeutics, 61, 1096-1109. [Google Scholar] [CrossRef] [PubMed]
[27] 钟华, 吴雪艳, 刘迪群. 血清胃蛋白酶原Ⅰ、Ⅱ及比值联合Hp抗体检测对早期胃癌的诊断价值[J]. 重庆医学, 2017, 46(6): 821-823.
[28] Sad, M., Aydinbelge, F.N., Koca, G. et al. (2019) Investigation of Helicobacter pylori Infection Prevalence Using C14-Urea Breath Test and Its Relationship with Socioeconomic, Family, and Environmental Factors. Jundishapur Journal of Microbiology, 12, e61884.
[29] 耿岚岚, 龚四堂. 重视儿童幽门螺杆菌感染的诊断与治疗[J]. 中国实用儿科杂志, 2016, 31(7): 490-493.
[30] 李中跃. 儿童幽门螺杆菌感染诊断方法及其临床应用[J]. 中国实用儿科杂志, 2016, 31(7): 500-504.
[31] 周仁民, 陈颖, 林琼. 白光胃镜下内镜征象诊断儿童幽门螺杆菌感染的临床研究[J]. 中国当代儿科杂志, 2025, 27(4): 438-443.
[32] 彭磊, 张伟锋, 李璇, 等. 幽门螺杆菌感染的内镜诊断及评价[J]. 中华消化内镜杂志, 2019, 36(9): 704-708.
[33] Yu, F., Qin, S., Wang, S. and Wang, J. (2021) Regular Arrangement of Collecting Venules (RAC) as an Endoscopic Marker for Exclusion of Helicobacter pylori (H. Pylori) Infection: A Systematic Review and Meta‐Analysis. International Journal of Clinical Practice, 75, e14548. [Google Scholar] [CrossRef] [PubMed]
[34] Saka, A., Yagi, K. and Nimura, S. (2015) Endoscopic and Histological Features of Gastric Cancers after Successful Helicobacter pylori Eradication Therapy. Gastric Cancer, 19, 524-530. [Google Scholar] [CrossRef] [PubMed]
[35] Kishino, M., Nakamura, S. and Shiratori, K. (2016) Clinical and Endoscopic Features of Undifferentiated Gastric Cancer in Patients with Severe Atrophic Gastritis. Internal Medicine, 55, 857-862. [Google Scholar] [CrossRef] [PubMed]
[36] 牛占岳, 周丽雅. 全球耐药趋势下中国幽门螺杆菌根除治疗进展[J]. 中华消化杂志, 2021, 41(10): 711-714.
[37] 施宏, 谢招飞, 黄贺, 等. 内镜诊断胃幽门螺杆菌感染的临床研究[J]. 中华消化杂志, 2016, 36(11): 781-784.
[38] 唐志锋, 高国明, 李硕权, 等. 成人幽门螺杆菌感染根除治疗失败危险因素的Meta分析[J]. 中国药房, 2025, 36(12): 1525-1529.
[39] 宋志强, 周丽雅. 幽门螺杆菌领域近十年临床研究进展和热点问题[J]. 中华内科杂志, 2024, 63(1): 1-4.